OHI vs SBRA

For growth investors, Omega Healthcare Investors, Inc.

(OHI) is the stronger pick with 14. 0% revenue growth year-over-year, versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 23. 8x trailing P/E (23. 4x forward), making it the more compelling value choice. Analysts rate Omega Healthcare Investors, Inc. (OHI) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Omega Healthcare Investors, Inc.

(OHI) is the cheapest at 23. 8x versus Sabra Health Care REIT, Inc. at 31. 8x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 4x.

Over the past 5 years, Omega Healthcare Investors, Inc.

(OHI) delivered a total return of +66. 3%, compared to +53. 4% for Sabra Health Care REIT, Inc. (SBRA). Over 10 years, the gap is even starker: OHI returned +114. 3% versus SBRA's +54. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.

(OHI) is the lower-risk stock at -0. 13β versus Sabra Health Care REIT, Inc. 's -0. 06β — meaning SBRA is approximately -49% more volatile than OHI relative to the S&P 500. On balance sheet safety, Omega Healthcare Investors, Inc. (OHI) carries a lower debt/equity ratio of 78% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Omega Healthcare Investors, Inc.

(OHI) is pulling ahead at 14. 0% versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). On earnings-per-share growth, the picture is similar: Omega Healthcare Investors, Inc. grew EPS 25. 2% year-over-year, compared to 18. 5% for Sabra Health Care REIT, Inc.. Over a 3-year CAGR, OHI leads at 10. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Omega Healthcare Investors, Inc.

(OHI) is the more profitable company, earning 49. 3% net margin versus 20. 1% for Sabra Health Care REIT, Inc. — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 34. 1% for SBRA. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Omega Healthcare Investors, Inc.

(OHI) trades at 23. 4x forward P/E versus 29. 5x for Sabra Health Care REIT, Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OHI: 6. 5% to $49. 14.

All stocks in this comparison pay dividends.

Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 5. 4% for Omega Healthcare Investors, Inc. (OHI).

For long-horizon retirement investors, Omega Healthcare Investors, Inc.

(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +114. 3% 10Y return). Both have compounded well over 10 years (OHI: +114. 3%, SBRA: +54. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.